|

Nociceptin Receptor Antagonist Clinical Trials

1 actively recruiting trial across 1 location

Also known as: BTRX-246040

Pipeline

Phase 2: 1

Top Sponsors

  • Mclean Hospital1

Indications

  • Anxiety Disorder1
  • Depression1
  • Anxiety1
  • Depressive Disorder, Major1

Belmont, Massachusetts1 trial

Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipulation

Mclean Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.